08
دی 3
Report on the effectiveness of a drug method in the treatment of knee osteoarthritis
Lorecivivint is superior to placebo for improving pain, function, and structure at 12 months and beyond in patients with knee osteoarthritis, according to data presented at ACR Convergence 2024.